Diplomat Pharmacy Q3 EPS $(2.35) Misses $(0.2) Estimate, Sales $1.3B Beat $1.17B Estimate

Diplomat Pharmacy (NYSE:DPLO) reported quarterly losses of $(2.35) per share which missed the analyst consensus estimate of $(0.2) by 1075 percent. The company reported quarterly sales of $1.3 billion which beat the

Benzinga · 11/12/2019 12:35

Diplomat Pharmacy (NYSE:DPLO) reported quarterly losses of $(2.35) per share which missed the analyst consensus estimate of $(0.2) by 1075 percent. The company reported quarterly sales of $1.3 billion which beat the analyst consensus estimate of $1.17 billion by 11.11 percent. This is a 5.32 percent decrease over sales of $1.373 billion the same period last year.